Pharmacology and Therapeutics
-
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
This article has 18 authors:Reviewed by ScreenIT
-
Role of pharmacist during the COVID-19 pandemic: A scoping review
This article has 3 authors:Reviewed by ScreenIT
-
Global research trend in the treatment of the new Coronavirus diseases (COVID-19): bibliometric analysis
This article has 2 authors:Reviewed by ScreenIT
-
Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review
This article has 6 authors:Reviewed by ScreenIT
-
Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety
This article has 2 authors:Reviewed by ScreenIT
-
Investigational Treatments for COVID‐19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions
This article has 7 authors:Reviewed by ScreenIT
-
Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol
This article has 8 authors:Reviewed by ScreenIT
-
Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports
This article has 5 authors:Reviewed by ScreenIT
-
Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients
This article has 16 authors:Reviewed by ScreenIT
-
Low blood sodium increases risk and severity of COVID-19: a systematic review, meta-analysis and retrospective cohort study
This article has 3 authors:Reviewed by ScreenIT